What does NT‑proBNP (N‑terminal pro‑B‑type natriuretic peptide) stand for?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

NT-proBNP Stands For: N-Terminal Pro-B-Type Natriuretic Peptide

NT-proBNP is the abbreviation for N-terminal pro-B-type natriuretic peptide, a cardiac biomarker that is released from the heart in response to ventricular wall stress and dysfunction 1, 2.

What NT-proBNP Represents

NT-proBNP is the N-terminal fragment that results when the precursor molecule proBNP (pro-B-type natriuretic peptide) is cleaved by proteolytic enzymes (furin and corin) 2. This cleavage produces two molecules:

  • BNP (B-type natriuretic peptide) - the biologically active hormone
  • NT-proBNP - the inactive N-terminal fragment that serves as a biomarker

Key Biochemical Characteristics

NT-proBNP has a longer biological half-life (25-70 minutes) compared to BNP (13-20 minutes), which makes it more stable for laboratory measurement 1. The peptide is:

  • A 76-amino acid peptide 3
  • Cleared passively by organs with high blood flow (kidneys 55-65%, liver 20-25%, musculoskeletal tissue 10-15%) 1
  • Stable at room temperature for at least 2 days 1

Clinical Significance

NT-proBNP is secreted from cardiac myocytes in response to:

  • Volume or pressure overload
  • Ventricular wall stress
  • Cardiac hemodynamic stress 1

The biomarker is widely used for diagnosis and management of heart failure, though it is neither heart failure-specific nor heart disease-specific 1. Levels are elevated in numerous cardiovascular and non-cardiovascular conditions including valvular disease, atrial fibrillation, renal failure, and pulmonary embolism 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.